Covance Genomics Laboratory and Ingenuity will work together to develop new and novel approaches, using Ingenuity’s IPA software, to obtain more actionable insights from NGS data and to answer research questions in a relevant biological context.
The collaboration brings together in genomics data production and analysis to develop new methodologies that integrate high-quality NGS data with knowledge generation and management tools.
By working together to generate the next generation of biological interpretation tools, Covance Genomics Laboratory will have the ability to help its pharmaceutical clients maximize the value of their investment in NGS technologies.
The collaboration enables researchers to quickly get to the intended high-value results of biomarker identification, target ID and validation, understanding drug mechanism of action, and safety assessment.